This review will summarise the connections between PPAR-γ interactions with agonists and the mechanisms involved in lung cellular processes in chronic diseases such as asthma, lung cancer, cystic fibrosis and chronic obstructive pulmonary disease (COPD). This evidence concerns the gene PPARG and asthma.